Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results

    NEXT STORY
    Amarin Highlights Key REDUCE-IT®-Related Data Presented at American Heart Association 2019 Scientific Sessions
    PREV STORY
    Amarin’s John Thero Awarded EY Entrepreneur of The Year® 2019 Life Sciences National Award
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aptevo Therapeutics Reports Third Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    Myriad Presents Two New Studies at the Western Section of the American Urological Association

    New Data Demonstrate the Clinical Performance of the Prolaris® and myRisk® Hereditary Cancer Genetic ...

    author_avatar
    NASDAQ Market News

    Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Lead-In to Phase 3, Global Registrational Trial of FPA144 in Front-Line Advanced Gastric Cancer

    SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), ...

    author_avatar
    NASDAQ Market News